Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to Companies who have applied for FDA Drug Approval
FDA Drug Approval Applications Sponsored by GLAXO GRP LTD
Application Number
Drugs/Products
Application Type
Most Recent Label Available Flag
Current Patent Flag
Action Type
Chemical Type
Ther Potential
Orphan Code
018703
ZANTAC 150
ZANTAC 300
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
019675
ZANTAC
New Drug Application
Approval
New formulation
(S) Standard review drug
020251
ZANTAC 150
ZANTAC 25
New Drug Application
Approval
New formulation
(S) Standard review drug
020833
FLOVENT DISKUS 100
FLOVENT DISKUS 250
FLOVENT DISKUS 50
New Drug Application
Approval
New formulation
(S) Standard review drug
021077
ADVAIR DISKUS 100/50
ADVAIR DISKUS 250/50
ADVAIR DISKUS 500/50
New Drug Application
Approval
New combination
(S) Standard review drug
021254
ADVAIR HFA
New Drug Application
Approval
New formulation
(S) Standard review drug
021433
FLOVENT HFA
New Drug Application
Approval
New formulation
(S) Standard review drug
125326
ARZERRA
Biologic License Application
Approval
204275
BREO ELLIPTA
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
Back to Companies who have applied for FDA Drug Approval